Cell cycle arrest by the PTEN tumor suppressor is target cell specific and may require protein phosphatase activity

Experimental Cell Research

Volumn 256, Issue 2, 2000, Pages 571-577

  Hlobilkova, Alice ^a   Guldberg, Per ^a   Thullberg, Minna ^a   Zeuthen, Jesper ^a   Lukas, Jiri ^a   Bartek, Jiri ^a  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

Author keywords

Breast cancer cell lines; Cell cycle; Protein phosphatase; PTEN tumor suppressor

Indexed keywords

ARTICLE; BREAST CANCER; CANCER SUSCEPTIBILITY; CELL CYCLE; CELL MIGRATION; CELL PROLIFERATION; CELL SPECIFICITY; CELL SYNCHRONIZATION; ENZYME ACTIVITY; GLIOMA; GROWTH INHIBITION; HUMAN; HUMAN CELL; MISSENSE MUTATION; PRIORITY JOURNAL; TARGET CELL; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

EID: 0034194403     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2000.4867     Document Type: Article

References (32)

1. Li J., Yen C., Liaw D., Podsypanina K., Bose S., Wang S. I., Puc J., Miliaresis C., Rodgers L., McCombie R., Bigner S. H., Giovanella B. C., Ittmann M., Tycko B., Hibshoosh H., Wigler M. H., Parsons R. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science. 275:1997;1943-1947.
2. Steck P. A., Pershouse M. A., Jasser S. A., Yung W. K., Lin H., Lign A. H., Langford L. A., Baugmard. M. L., Hattier T., Davis T., Frye C., Hu R., Swedlund B., Teng. D. H., Tavtigian S. V. Identification of a candidate tumor suppressor gene MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat. Genet. 15:1997;356-362.
3. Li D. M., Sun H. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. Cancer Res. 57:1997;2124-2129.
4. Besson A., Robbins S. M., Yong V. W. PTEN/MMAC1/TEP1 in signal transduction and tumorigenesis. Eur. J. Biochem. 263:1999;237-245.
5. Di Cristofano A., Pesce B., Cordon-Cardo C., Pandolfi P. P. Pten is essential for embryonic development and tumour suppression. Nat. Genet. 19:1998;348-355.
6. Suzuki A., de la Pompa J. L., Stambolic V., Elia A. J., Sasaki T., del Barco-Barrantes I., Ho A., Wakeham A., Itie A., Khoo W., Fukumoto M., Mak T. W. High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice. Curr. Biol. 8:1998;1169-1178.
7. Podsypanina K., Ellenson L. H., Nemes A., Gu J., Tamura M., Yamada K. M., Cordon-Cardo C., Catoretti G., Fisher P. E., Parsons R. Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proc. Natl. Acad. Sci. USA. 96:1999;1563-1568.
8. Guldberg P., thor Straten P., Birck A., Ahrenkiel V., Kirkin A. F., Zeuthen J. Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma. Cancer Res. 57:1997;3660-3663.
9. Myers M. P., Stolarov J. P., Eng C., Li J., Wang S. I., Wigler M. H., Parsons R., Tonks N. K. PTEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc. Natl. Acad. Sci. USA. 94:1997;9052-9057.
10. Tonks N. K., Myers M. P. Structural assets of a tumor suppressor. Science. 286:1999;2096-2097.
11. Lee J.-O., Yang H., Georgescu M., Di Cristofano A., Maehama T., Shi Y., Dixon J. E., Pandolfi P., Pavletich N. P. Crystal structure of the PTEN tumor suppressor: Implications for its phosphoinositide phosphatase activity and membrane association. Cell. 99:1999;323-334.
12. Li J., Simpson L., Takahashi M., Miliaresis C., Myers M. P., Tonks N., Parsons R. The PTEN/MMAC1 tumor suppressor induces cell death that is rescued by the AKT/protein kinase B oncogene. Cancer Res. 58:1998;5667-5672.
13. Myers M. P., Pass I., Batty I. H., Van der Kaay J., Stolarov J. P., Hemmings B. A., Wigler M. H., Downes C. P., Tonks N. K. The lipid phosphatase activity of PTEN is critical for its tumor suppressor function. Proc. Natl. Acad. Sci. USA. 95:1998;13513-13518.
14. Furnari F. B., Lin H., Huang H. S., Cavenee W. K. Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain. Proc. Natl. Acad. Sci. USA. 94:1997;12479-12484.
15. Davies M. A., Lu Y., Sano T., Fang X., Tang P., LaPushin R., Koul D., Bookstein R., Stokoe D., Yung W. K., Mills G. B., Steck P. A. Adenoviral transgene expression of MMAC/PTEN in human glioma cells inhibits Akt activation and induces anoikis. Cancer Res. 58:1998;5285-5290.
16. Furnari F. B., Huang H. J., Cavenee W. K. The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G1 growth arrest in glioma cells. Cancer Res. 58:1998;5002-5008.
17. Weng L. P., Smith W. M., Dahia P. L. M., Ziebold U., Gil E., Lees J. A., Eng C. PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death. Cancer Res. 59:1999;5808-5814.
18. Li D. M., Sun H. PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells. Proc. Natl. Acad. Sci. USA. 95:1998;15406-15411.
19. Tamura M., Gu J., Matsumoto K., Aota S., Parsons R., Yamada K. M. Inhibition of cell migration, spreading, and focal adhesion by tumor suppressor PTEN. Science. 280:1998;1614-1617.
20. Tamura M., Gu J., Takino T., Yamada K. M. Tumor suppressor PTEN inhibition of cell invasion, migration, and growth: Differential involvement of focal adhesion kinase and p130Cas. Cancer Res. 59:1999;442-449.
21. Stambolic V., Suzuki A., Lois de la Pompa J., Brothers G. M., Mirtsos C., Sasaki T., Rudland J., Penninger J. M., Siderovski D. P., Mak T. W. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell. 95:1998;29-39.
22. Cheney I. W., Johnson D. E., Vaillancourt M. T., Avanzini J., Morimoto A., Demers G. W., Wills K. N., Shabram P. W., Bolen J. B., Tavtigian S. V., Bookstein R. Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer. Cancer Res. 58:1998;2331-2334.
23. Morimoto A. M., Berson A. E., Fujii G. H., Teng D. H., Tavtigian S. V., Bookstein R., Steck P. A., Bolen J. B. Phenotypic analysis of human glioma cells expressing the MMAC1 tumor suppressor phosphatase. Oncogene. 18:1999;1261-1266.
24. Wick W., Furnari F. B., Naumann U., Cavenee W. K., Weller M. PTEN gene transfer in human malignant glioma: Sensitization to irradiation and CD95L-induced apoptosis. Oncogene. 18:1999;3936-3943.
25. Lukas J., Parry D., Aagaard L., Mann D. J., Bartkova J., Strauss M., Peters G., Bartek J. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature. 375:1995;503-506.
26. Lukas J., Pagano M., Staskova Z., Draetta G., Bartek J. Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines. Oncogene. 9:1994;707-718.
27. Lukas J., Petersen B. O., Holm K., Bartek J., Helin K. Deregulated expression of E2F family members induces S-phase entry and overcomes p16INK4A-mediated growth suppression. Mol. Cell. Biol. 16:1996;1047-1057.
28. Bartkova J., Zemanova M., Bartek J. Expression of CDK7/CAK in normal and tumour cells of diverse histogenesis, cell-cycle position, and differentiation stage. Int. J. Cancer. 66:1996;732-737.
29. Liaw D., Marsh D. J., Li J., Dahia P. L., Wang S. I., Zheng Z., Bose S., Call K. M., Tsou H. C., Peacocke M., Eng C., Parsons R. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat. Genet. 16:1997;64-67.
30. Maier D., Jones G., Li X., Schonthal A. H., Gratzl O., Van Meir E. G., Merlo A. The PTEN lipid phosphatase domain is not required to inhibit invasion of glioma cells. Cancer Res. 59:1999;5479-5482.
31. Levine A. J. p53, the cellular gatekeeper for growth and division. Cell. 88:1997;323-331.
32. Bartek J., Bartkova J., Lukas J. The retinoblastoma protein pathway in cell cycle control and cancer. Exp. Cell Res. 237:1997;1-6.